These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 25831418

  • 1. Genetic analysis of invasive pneumococcal isolates from children in Ontario, Canada, 2007-2012.
    Deng X, Arya G, Memari N, Mackenzie R, MacMullin G, Low DE, Pillai DR, Gubbay JB.
    Pediatr Infect Dis J; 2015 Jun; 34(6):594-8. PubMed ID: 25831418
    [Abstract] [Full Text] [Related]

  • 2. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
    Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B, Active Bacterial Core Surveillance Team.
    J Infect Dis; 2005 Dec 01; 192(11):1988-95. PubMed ID: 16267772
    [Abstract] [Full Text] [Related]

  • 3. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
    Moore MR, Gertz RE, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B.
    J Infect Dis; 2008 Apr 01; 197(7):1016-27. PubMed ID: 18419539
    [Abstract] [Full Text] [Related]

  • 4. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S, Fujisawa T, Ito Y, Chang B, Suga S, Noguchi T, Yamamoto M, Matsumura Y, Nagao M, Takakura S, Ohnishi M, Ihara T, Ichiyama S.
    Vaccine; 2016 Jan 02; 34(1):67-76. PubMed ID: 26602268
    [Abstract] [Full Text] [Related]

  • 5. Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.
    Yildirim I, Stevenson A, Hsu KK, Pelton SI.
    Pediatr Infect Dis J; 2012 Oct 02; 31(10):1016-21. PubMed ID: 22673142
    [Abstract] [Full Text] [Related]

  • 6. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.
    Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Mason EO.
    Pediatr Infect Dis J; 2013 Mar 02; 32(3):203-7. PubMed ID: 23558320
    [Abstract] [Full Text] [Related]

  • 7. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, McCracken GH.
    Pediatr Infect Dis J; 2010 Apr 02; 29(4):294-300. PubMed ID: 19949357
    [Abstract] [Full Text] [Related]

  • 8. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH.
    Pediatr Infect Dis J; 2007 Jun 02; 26(6):461-7. PubMed ID: 17529859
    [Abstract] [Full Text] [Related]

  • 9. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM, Memish ZA, Al-Kattan KM.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [Abstract] [Full Text] [Related]

  • 10. Increase of pneumococcal serotype 19A in Italy is due to expansion of the piliated clone ST416/CC199.
    Del Grosso M, Camilli R, D'Ambrosio F, Petrucci G, Melchiorre S, Moschioni M, Gherardi G, Pantosti A.
    J Med Microbiol; 2013 Aug 31; 62(Pt 8):1220-1225. PubMed ID: 23722433
    [Abstract] [Full Text] [Related]

  • 11. Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.
    Pichon B, Ladhani SN, Slack MP, Segonds-Pichon A, Andrews NJ, Waight PA, Miller E, George R.
    J Clin Microbiol; 2013 Mar 31; 51(3):820-7. PubMed ID: 23269742
    [Abstract] [Full Text] [Related]

  • 12. Dominance of multidrug-resistant Denmark(14)-32 (ST230) clone among Streptococcus pneumoniae serotype 19A isolates causing pneumococcal disease in Bulgaria from 1992 to 2013.
    Setchanova LP, Alexandrova A, Dacheva D, Mitov I, Kaneva R, Mitev V.
    Microb Drug Resist; 2015 Feb 31; 21(1):35-42. PubMed ID: 25080213
    [Abstract] [Full Text] [Related]

  • 13. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.
    Phongsamart W, Srifeungfung S, Chatsuwan T, Nunthapisud P, Treerauthaweeraphong V, Rungnobhakhun P, Sricharoenchai S, Chokephaibulkit K.
    Hum Vaccin Immunother; 2014 Feb 31; 10(7):1866-73. PubMed ID: 25424794
    [Abstract] [Full Text] [Related]

  • 14. Population structure of invasive Streptococcus pneumoniae isolates among Alaskan children in the conjugate vaccine era, 2001 to 2013.
    Miernyk KM, Bulkow LR, Case SL, Zulz T, Bruce MG, Harker-Jones M, Hurlburt DA, Hennessy TW, Rudolph KM.
    Diagn Microbiol Infect Dis; 2016 Oct 31; 86(2):224-30. PubMed ID: 27498610
    [Abstract] [Full Text] [Related]

  • 15. Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011.
    Hulten KG, Kaplan SL, Lamberth LB, Barson WJ, Romero JR, Lin PL, Bradley JS, Givner LB, Tan TQ, Hoffman JA, Mason EO.
    J Clin Microbiol; 2013 Apr 31; 51(4):1294-7. PubMed ID: 23390277
    [Abstract] [Full Text] [Related]

  • 16. Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine.
    Elberse KE, van der Heide HG, Witteveen S, van de Pol I, Schot CS, van der Ende A, Berbers GA, Schouls LM.
    Vaccine; 2012 Dec 14; 30(52):7644-51. PubMed ID: 22521844
    [Abstract] [Full Text] [Related]

  • 17. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E, Albert MJ.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [Abstract] [Full Text] [Related]

  • 18. Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children.
    Varon E, Cohen R, Béchet S, Doit C, Levy C.
    Vaccine; 2015 Nov 17; 33(46):6178-85. PubMed ID: 26476365
    [Abstract] [Full Text] [Related]

  • 19. Genetic structures of invasive Streptococcus pneumoniae isolates from Korean children obtained between 1995 and 2013.
    Yun KW, Choi EH, Lee HJ, Kang JH, Kim KH, Kim DS, Kim YJ, Eun BW, Oh SH, Cho HK, Hong YJ, Kim KN, Kim NH, Kim YK, Lee H, Lee T, Kim HM, Cho EY, Kim CS, Park SE, Oh CE, Jo DS, Choi YY, Lee J.
    BMC Infect Dis; 2018 Jun 08; 18(1):268. PubMed ID: 29884115
    [Abstract] [Full Text] [Related]

  • 20. Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
    Golden AR, Adam HJ, Karlowsky JA, Baxter M, Nichol KA, Martin I, Demczuk W, Van Caeseele P, Gubbay JB, Lefebvre B, Levett PN, Zahariadis G, Haldane D, Gad R, German G, Gilmour MW, Mulvey MR, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    J Antimicrob Chemother; 2018 Jul 01; 73(suppl_7):vii20-vii31. PubMed ID: 29982573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.